Beximco Pharmaceuticals Limited announced earnings results for the full year ended June 30, 2020. For the full year, the company announced sales was BDT 25,611.947 million compared to BDT 22,816.629 million a year ago. Operating income was BDT 5,609.494 million compared to BDT 5,066.173 million a year ago. Net income was BDT 3,514.687 million compared to BDT 3,033.402 million a year ago. Basic earnings per share from continuing operations was BDT 8.67 compared to BDT 7.48 a year ago.